TGFB1 and chronic kidney disease: Activation of TGF-β pathway (largely driven by TGF-β1 isoform) in fibrosis and potent upregulation of Smad2 and Smad3 proteins have been demonstrated both in human and in animal models of chronic kidney disease [3].